Munich-based biotech 2NA FISH, a former Medical Valley Award winner, has secured additional pre-seed funding led by GF BRYCK Ventures with follow-on investment from Twip to further develop its spatial RNA biomarker detection platform and make it practical for routine pathology workflows. The funding will support validation, early-access collaborations, and enhancement of the platform’s AI-based analysis software.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently seeing a placeholder content of Mailchimp. To access the actual content, click on the button below. Please note that data will be passed on to third-party providers.
More informationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information
